|
|
|||
|
|||
|
|
|||
|
allergies and weight gain |
|||
|
|
|||
|
|||
 
|
|||
|
|
|||
|
allergies and weight gain DESCRIPTION Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide allergies and weight gain. The molecular weight of zafirlukast is 575.7 and the structural formula is:
Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water allergies and weight gain. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone allergies and weight gain. ACCOLATE is supplied as 10 and 20 mg tablets for oral administration allergies and weight gain. Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide allergies and weight gain.
In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans allergies and weight gain. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs allergies and weight gain. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness allergies and weight gain. In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges allergies and weight gain. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma allergies and weight gain. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma allergies and weight gain. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge allergies and weight gain. Clinical Pharmacokinetics and Bioavailability: Distribution Metabolism Excretion In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma allergies and weight gain. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma allergies and weight gain. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg allergies and weight gain. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data allergies and weight gain. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% allergies and weight gain. The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below allergies and weight gain. Mean (% Coefficient of Variation) pharmacokinetic
Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed allergies and weight gain. Elderly: The apparent oral clearance of zafirlukast decreases with age allergies and weight gain. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients allergies and weight gain. Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained: Parameter Children age
Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults allergies and weight gain. Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects allergies and weight gain. Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects allergies and weight gain. Drug-Drug Interactions
|
|||
 
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| aallergies and weight gain alllergies and weight gain alllergies and weight gain alleergies and weight gain allerrgies and weight gain allerggies and weight gain allergiies and weight gain allergiees and weight gain allergiess and weight gain allergies and weight gain allergies aand weight gain allergies annd weight gain allergies andd weight gain allergies and weight gain allergies and wweight gain allergies and weeight gain allergies and weiight gain allergies and weigght gain allergies and weighht gain allergies and weightt gain allergies and weight gain allergies and weight ggain allergies and weight gaain allergies and weight gaiin allergies and weight gainn llergies and weight gain alergies and weight gain alergies and weight gain allrgies and weight gain allegies and weight gain alleries and weight gain allerges and weight gain allergis and weight gain allergie and weight gain allergiesand weight gain allergies nd weight gain allergies ad weight gain allergies an weight gain allergies andweight gain allergies and eight gain allergies and wight gain allergies and weght gain allergies and weiht gain allergies and weigt gain allergies and weigh gain allergies and weightgain allergies and weight ain allergies and weight gin allergies and weight gan allergies and weight gai a llergies and weight gain al lergies and weight gain all ergies and weight gain alle rgies and weight gain aller gies and weight gain allerg ies and weight gain allergi es and weight gain allergie s and weight gain allergies and weight gain allergies and weight gain allergies a nd weight gain allergies an d weight gain allergies and weight gain allergies and weight gain allergies and w eight gain allergies and we ight gain allergies and wei ght gain allergies and weig ht gain allergies and weigh t gain allergies and weight gain allergies and weight gain allergies and weight g ain allergies and weight ga in allergies and weight gai n allergies and weight gain lalergies and weight gain allergies and weight gain alelrgies and weight gain allregies and weight gain allegries and weight gain alleriges and weight gain allergeis and weight gain allergise and weight gain allergie sand weight gain allergiesa nd weight gain allergies nad weight gain allergies adn weight gain allergies an dweight gain allergies andw eight gain allergies and ewight gain allergies and wieght gain allergies and wegiht gain allergies and weihgt gain allergies and weigth gain allergies and weigh tgain allergies and weightg ain allergies and weight agin allergies and weight gian allergies and weight gani aallergies and weight gain theallergies and weight gain allergies and weight gain | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |
